Xenon Pharma (XENE.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec5

Xenon Pharmaceuticals Announces 48-Month Study Results for Azetukalner in Refractory Epilepsy

14:00

Nov25

Xenon Pharmaceuticals to Present New Clinical Data on Azetukalner at AES 2025

13:30

Nov6

Wedbush Analyst Cuts Xenon Pharmaceuticals FY2029 EPS Estimate

14:17

Nov5

Xenon Pharmaceuticals Highlights Optimism from Clinical Progress and Financial Status

00:57

Nov4

Gerberry Recommends Healthcare Stocks; H.C. Wainwright Reiterates Xenon Buy Rating

15:08

Xenon Pharma released FY2025 9 Months Earnings on November 3 After-Market EST, Actual Revenue: USD 7.5 M, Actual EPS: USD -3.0495

00:00

Schedules & Filings

Schedules

Filings

Nov3

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -90.9 M, EPS -1.1469

Aug11

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -84.71 M, EPS -1.0728

May12

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 7.5 M, Net Income -65.05 M, EPS -0.8266

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change